drugset / Trial / NCT03774745

Blocking Mifepristone Action With Progesterone

NCT03774745

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Double-blind randomized trial to evaluate the potential impact of progesterone treatment on early pregnancies exposed to mifepristone.

Timeline

Start
2019-02-11
Primary completion
2019-07-29
Completion
2019-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Progesterone Other / unclassified 400 mg Oral
Background Mifepristone Small molecule 200 mg Oral

Indications

No indication recorded.